All Sauce from Weekly Sauce:

Cases of a parasitic disease spread by ticks have been on the rise, particularly in states in the Northeast that had previously seen few cases, U.S. health officials reported Friday. Between 2011 and 2019, more than 16,000 cases of babesiosis were reported in the United States, with the lion’s share of those cases reported in…  read on >  read on >

Considered one of the most common sexually transmitted diseases, chlamydia can spread easily and often without obvious symptoms. And although chlamydia cases have declined in recent years, the U.S. Centers for Disease Control and Prevention chalks that up to reduced screening for sexually transmitted diseases (STDs) during the pandemic. It is estimated that 1 in…  read on >  read on >

Hair loss can be devastating for women, but the condition can also signal additional health problems. An American Academy of Dermatology expert offers information about the types of hair loss seen in women with darker skin tones, common types of medical conditions associated with hair loss and treatment options. “Research shows that women who experience…  read on >  read on >

Many patients worry that receiving a metal implant might set off their metal allergy, according to the American Academy of Dermatology. “Cases in which patients are inquiring about a metal allergy as it relates to their metal implants — including joint replacements, rods, pins, screws, plates, certain neurologic and cardiac devices such as pacemakers, and…  read on >  read on >

Paxlovid, a medication that has helped millions of high-risk COVID patients avoid hospitalization and death since late 2021, moved one step closer to getting full approval from the U.S. Food and Drug Administration on Thursday. An FDA advisory panel voted 16-1 that the Pfizer drug remains a safe and effective treatment and should be given…  read on >  read on >

Just like adults, young children with type 1 diabetes may get the blood sugar control they need using an “artificial pancreas,” new research shows. The Control-IQ artificial pancreas system was tested in a clinical trial in children aged 2 to 6. Using the technology developed at the University of Virginia (UVA), these children spent approximately…  read on >  read on >